,Diagnosis,Treatment code,Diagnosis code,case Specialism code,Diagnosis Treatment Combination ID,Age,Case ID,Activity,Producer code,Section,Specialism code,group,Number of executions,Complete Timestamp,duration,month,weekday,hour,remtime,elapsed,case_length
311,maligniteit cervix,TC3101,DC822,SC7,DTC153637,39.0,1,AC419100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-01-03 09:00:00,0.0,1.0,0.0,9.0,30412800.0,0.0,1
515,maligniteit ovarium | tuba,TC803,M16,SC7,DTC151957,31.0,4,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-03 09:00:00,0.0,1.0,0.0,9.0,71539200.0,0.0,1
609,maligniteit vagina,TC101,M12,SC7,DTC153624,42.0,6,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-06 09:00:00,0.0,1.0,3.0,9.0,2246400.0,0.0,1
1190,maligniteit vulva,TC603,M11,SC7,DTC154119,59.0,8,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-07 09:00:00,0.0,1.0,4.0,9.0,97891200.0,0.0,1
2682,Gynaecologische tumoren,TC11,DC106,SC7,DTC376967,30.0,13,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-01-11 09:00:00,0.0,1.0,1.0,9.0,6134400.0,0.0,1
3305,maligniteit vulva,TC101,M11,SC7,other,63.0,19,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-13 09:00:00,0.0,1.0,3.0,9.0,97372800.0,0.0,1
3492,maligniteit vulva,TC101,M11,SC7,DTC159154,65.0,21,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-16 09:00:00,0.0,1.0,6.0,9.0,83808000.0,0.0,1
3630,maligniteit cervix,TC61,DC106,SC61,DTC391976,66.0,22,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-17 09:00:00,0.0,1.0,0.0,9.0,7516800.0,0.0,1
4181,maligniteit cervix,TC4401,DC822,SC61,DTC172800,40.0,23,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-17 09:00:00,0.0,1.0,0.0,9.0,99878400.0,0.0,1
4747,maligniteit cervix,TC13,DC106,SC61,DTC177238,37.0,24,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-19 09:00:00,0.0,1.0,2.0,9.0,61171200.0,0.0,1
5588,maligniteit ovarium | tuba,TC803,DC821,SC7,DTC164424,55.0,30,370419S,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-01-24 09:00:00,0.0,1.0,0.0,9.0,99273600.0,0.0,1
5659,maligniteit cervix,TC101,M13,SC7,other,34.0,31,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-01-26 09:00:00,0.0,1.0,2.0,9.0,27216000.0,0.0,1
5782,Gynaecologische tumoren,TC101,DC106,SC61,DTC377076,61.0,32,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-01-27 09:00:00,0.0,1.0,3.0,9.0,86400000.0,0.0,1
6370,maligniteit vulva,TC101,M11,SC7,other,48.0,40,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-03 09:00:00,0.0,2.0,3.0,9.0,93139200.0,0.0,1
7350,maligniteit ovarium | tuba,TC12,DC106,SC61,DTC390809,74.0,47,370715S,CRPO,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-07 09:00:00,0.0,2.0,0.0,9.0,16416000.0,0.0,1
7533,Gynaecologische tumoren,TC61,DC106,SC7,DTC350945,35.0,49,AC411100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-02-08 09:00:00,0.0,2.0,1.0,9.0,95731200.0,0.0,1
7691,maligniteit cervix,TC603,M13,SC7,DTC174472,54.0,52,AC378546,LBAC,Section 4,SC87,Medical Microbiology,1.0,2005-02-09 09:00:00,0.0,2.0,2.0,9.0,23068800.0,0.0,1
9073,maligniteit ovarium | tuba,TC101,M16,SC7,DTC207517,71.0,63,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-14 09:00:00,0.0,2.0,0.0,9.0,92620800.0,0.0,1
9384,maligniteit vulva,TC101,M11,SC7,other,58.0,66,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-17 09:00:00,0.0,2.0,3.0,9.0,68256000.0,0.0,1
9394,maligniteit vulva,TC101,M11,SC7,DTC179033,43.0,67,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-17 09:00:00,0.0,2.0,3.0,9.0,96163200.0,0.0,1
9569,maligniteit vulva,TC101,M11,SC7,DTC179035,68.0,68,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-17 09:00:00,0.0,2.0,3.0,9.0,97200000.0,0.0,1
9705,maligniteit cervix,TC101,M13,SC7,other,45.0,70,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-17 09:00:00,0.0,2.0,3.0,9.0,0.0,0.0,1
9709,maligniteit ovarium | tuba,TC101,M16,SC7,other,63.0,71,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-17 09:00:00,0.0,2.0,3.0,9.0,39052800.0,0.0,1
11060,maligniteit ovarium,TC3101,DC821,SC7,DTC182586,70.0,72,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-17 09:00:00,0.0,2.0,3.0,9.0,33091200.0,0.0,1
13229,Gynaecologische tumoren,TC61,DC106,SC7,DTC263802,69.0,78,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-23 09:00:00,0.0,2.0,2.0,9.0,77500800.0,0.0,1
13367,maligniteit endometrium,TC103,M14,SC61,DTC389776,86.0,79,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-23 09:00:00,0.0,2.0,2.0,9.0,13910400.0,0.0,1
13540,maligniteit vagina,TC113,M12,SC7,DTC183570,64.0,81,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-02-24 09:00:00,0.0,2.0,3.0,9.0,9158400.0,0.0,1
13607,maligniteit vagina,TC101,M12,SC7,DTC185363,74.0,85,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-02-28 09:00:00,0.0,2.0,0.0,9.0,86659200.0,0.0,1
15260,maligniteit ovarium | tuba,TC101,M16,SC7,DTC186996,61.0,91,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-02 09:00:00,0.0,3.0,2.0,9.0,73008000.0,0.0,1
15579,maligniteit cervix,TC813,M13,SC7,DTC188021,43.0,93,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-03 09:00:00,0.0,3.0,3.0,9.0,93225600.0,0.0,1
15611,maligniteit ovarium | tuba,TC101,M16,SC7,DTC187962,57.0,94,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-03 09:00:00,0.0,3.0,3.0,9.0,7257600.0,0.0,1
15906,maligniteit vulva,TC603,M11,SC7,DTC189524,57.0,96,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-07 09:00:00,0.0,3.0,0.0,9.0,80438400.0,0.0,1
16579,Gynaecologische tumoren,TC13,DC106,SC7,DTC236621,28.0,98,AC390550,RATH,Section 5,SC61,Radiotherapy,1.0,2005-03-07 09:00:00,0.0,3.0,0.0,9.0,9417600.0,0.0,1
17093,maligniteit cervix,TC101,M13,SC7,other,51.0,102,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-09 09:00:00,0.0,3.0,2.0,9.0,47779200.0,0.0,1
17729,maligniteit vulva,TC803,M11,SC7,DTC193870,51.0,110,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-14 09:00:00,0.0,3.0,0.0,9.0,91411200.0,0.0,1
17814,maligniteit cervix,TC813,M13,SC7,DTC193760,27.0,112,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-14 09:00:00,0.0,3.0,0.0,9.0,91411200.0,0.0,1
18966,maligniteit cervix,TC101,M13,SC7,DTC343607,41.0,117,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-16 09:00:00,0.0,3.0,2.0,9.0,92620800.0,0.0,1
19021,maligniteit endometrium,TC603,M14,SC7,DTC195713,64.0,118,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2005-03-16 09:00:00,0.0,3.0,2.0,9.0,14515200.0,0.0,1
19864,maligniteit cervix,TC813,M13,SC7,DTC196365,48.0,123,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-17 09:00:00,0.0,3.0,3.0,9.0,88732800.0,0.0,1
20004,Gynaecologische tumoren,TC61,DC106,SC7,DTC207555,45.0,125,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-17 09:00:00,0.0,3.0,3.0,9.0,89337600.0,0.0,1
20080,maligniteit cervix,TC603,M13,SC7,DTC197882,41.0,126,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-21 09:00:00,0.0,3.0,0.0,9.0,7430400.0,0.0,1
20320,Gynaecologische tumoren,TC13,DC106,SC61,DTC389827,72.0,128,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-03-23 09:00:00,0.0,3.0,2.0,9.0,66960000.0,0.0,1
20439,maligniteit ovarium | tuba,TC603,M16,SC7,DTC199520,56.0,130,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-23 09:00:00,0.0,3.0,2.0,9.0,5875200.0,0.0,1
21558,maligniteit ovarium,TC3101,DC821,SC13,DTC210970,70.0,131,370489S,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-23 09:00:00,0.0,3.0,2.0,9.0,49766400.0,0.0,1
21915,maligniteit cervix,TC113,M13,SC61,DTC390006,70.0,134,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-24 09:00:00,0.0,3.0,3.0,9.0,59875200.0,0.0,1
21953,Gynaecologische tumoren,TC61,DC106,SC7,other,54.0,135,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-24 09:00:00,0.0,3.0,3.0,9.0,75945600.0,0.0,1
22208,Gynaecologische tumoren,TC13,DC106,SC61,DTC390466,73.0,136,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-03-24 09:00:00,0.0,3.0,3.0,9.0,58406400.0,0.0,1
22257,maligniteit ovarium | tuba,TC101,M16,SC7,DTC200101,24.0,137,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2005-03-24 09:00:00,0.0,3.0,3.0,9.0,66528000.0,0.0,1
22898,maligniteit vulva,TC603,M11,SC7,DTC213044,34.0,142,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-30 09:00:00,0.0,3.0,2.0,9.0,85968000.0,0.0,1
23147,maligniteit ovarium | tuba,TC101,M16,SC7,DTC241184,28.0,149,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-30 09:00:00,0.0,3.0,2.0,9.0,70156800.0,0.0,1
23271,maligniteit ovarium | tuba,TC101,M16,SC7,other,75.0,151,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-30 09:00:00,0.0,3.0,2.0,9.0,0.0,0.0,1
23386,maligniteit cervix,TC101,M13,SC7,DTC275638,57.0,153,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-03-31 09:00:00,0.0,3.0,3.0,9.0,44150400.0,0.0,1
23461,maligniteit vulva,TC101,M11,SC7,DTC256603,60.0,157,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-04 09:00:00,0.0,4.0,0.0,9.0,88992000.0,0.0,1
23480,Gynaecologische tumoren,TC61,DC106,SC7,other,54.0,159,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-05 09:00:00,0.0,4.0,1.0,9.0,70243200.0,0.0,1
23811,maligniteit vulva,TC503,M11,SC7,DTC206417,82.0,166,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-07 09:00:00,0.0,4.0,3.0,9.0,49507200.0,0.0,1
23852,maligniteit cervix,TC101,DC106,SC7,DTC208202,35.0,168,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-04-07 09:00:00,0.0,4.0,3.0,9.0,66009600.0,0.0,1
24222,maligniteit ovarium | tuba,TC101,M16,SC7,other,58.0,172,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-12 09:00:00,0.0,4.0,1.0,9.0,50284800.0,0.0,1
24393,maligniteit cervix,TC101,M13,SC7,other,36.0,178,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-14 09:00:00,0.0,4.0,3.0,9.0,34214400.0,0.0,1
24403,maligniteit endometrium,TC101,M14,SC7,other,70.0,179,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-14 09:00:00,0.0,4.0,3.0,9.0,82598400.0,0.0,1
24553,maligniteit ovarium | tuba,TC101,M16,SC7,DTC222688,52.0,183,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-18 09:00:00,0.0,4.0,0.0,9.0,90374400.0,0.0,1
24602,maligniteit cervix,TC101,M13,SC7,other,57.0,186,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-20 09:00:00,0.0,4.0,2.0,9.0,65318400.0,0.0,1
25284,Maligne neoplasma ovarium,TC102,DC821,SC13,DTC259650,61.0,190,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-21 09:00:00,0.0,4.0,3.0,9.0,72489600.0,0.0,1
26379,maligniteit vulva,TC101,M11,SC7,other,85.0,196,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-27 09:00:00,0.0,4.0,2.0,9.0,82857600.0,0.0,1
27086,Gynaecologische tumoren,TC61,DC106,SC61,other,76.0,201,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-27 09:00:00,0.0,4.0,2.0,9.0,71798400.0,0.0,1
27103,maligniteit vulva,TC101,M11,SC7,other,49.0,203,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-04-28 09:00:00,0.0,4.0,3.0,9.0,38620800.0,0.0,1
27113,maligniteit vulva,TC101,M11,SC7,other,69.0,205,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-02 09:00:00,0.0,5.0,0.0,9.0,47433600.0,0.0,1
27186,maligniteit endometrium,TC3101,DC823,SC7,DTC247902,48.0,206,AC411100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-05-02 09:00:00,0.0,5.0,0.0,9.0,81216000.0,0.0,1
27917,maligniteit ovarium,TC3101,DC821,SC7,DTC295720,28.0,209,370443S,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-05-07 09:00:00,0.0,5.0,5.0,9.0,40262400.0,0.0,1
28352,maligniteit vulva,TC101,M11,SC7,other,53.0,212,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-10 09:00:00,0.0,5.0,1.0,9.0,75772800.0,0.0,1
28406,maligniteit vulva,TC803,M11,SC7,DTC229783,76.0,213,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-05-11 09:00:00,0.0,5.0,2.0,9.0,41558400.0,0.0,1
28446,maligniteit cervix,TC101,M13,SC7,other,44.0,215,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-11 09:00:00,0.0,5.0,2.0,9.0,45360000.0,0.0,1
29023,maligniteit ovarium | tuba,TC101,M16,SC7,other,53.0,219,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-11 09:00:00,0.0,5.0,2.0,9.0,65232000.0,0.0,1
29061,maligniteit ovarium | tuba,TC101,M16,SC7,DTC238886,63.0,220,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-13 09:00:00,0.0,5.0,4.0,9.0,79056000.0,0.0,1
29653,maligniteit ovarium,TC3201,DC821,SC7,DTC233544,60.0,228,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-18 09:00:00,0.0,5.0,2.0,9.0,13392000.0,0.0,1
30035,maligniteit vulva,TC503,M11,SC7,DTC236513,86.0,231,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-23 09:00:00,0.0,5.0,0.0,9.0,3715200.0,0.0,1
30562,maligniteit ovarium,TC803,DC821,SC13,DTC241472,62.0,233,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-05-23 09:00:00,0.0,5.0,0.0,9.0,79401600.0,0.0,1
31435,maligniteit endometrium,TC101,M14,SC7,other,46.0,237,AC10307,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-25 09:00:00,0.0,5.0,2.0,9.0,55123200.0,0.0,1
31488,Gynaecologische tumoren,TC103,DC106,SC61,DTC391195,73.0,238,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-05-25 09:00:00,0.0,5.0,2.0,9.0,54691200.0,0.0,1
31512,maligniteit vulva,TC101,M11,SC7,other,75.0,240,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-26 09:00:00,0.0,5.0,3.0,9.0,0.0,0.0,1
32032,maligniteit myometrium,TC101,M15,SC7,DTC247907,46.0,243,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-05-26 09:00:00,0.0,5.0,3.0,9.0,76723200.0,0.0,1
32162,maligniteit ovarium | tuba,TC603,M16,SC7,DTC239225,19.0,244,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-05-26 09:00:00,0.0,5.0,3.0,9.0,88732800.0,0.0,1
32978,maligniteit cervix,TC113,M13,SC7,DTC243125,71.0,248,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-06-01 09:00:00,0.0,6.0,2.0,9.0,22377600.0,0.0,1
33007,maligniteit cervix,TC101,M13,SC7,DTC243132,87.0,249,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-01 09:00:00,0.0,6.0,2.0,9.0,0.0,0.0,1
33363,maligniteit cervix,TC101,M13,SC7,other,51.0,252,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-02 09:00:00,0.0,6.0,3.0,9.0,20563200.0,0.0,1
33555,maligniteit vulva,TC101,M11,SC7,DTC245603,55.0,254,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-06 09:00:00,0.0,6.0,0.0,9.0,68947200.0,0.0,1
33788,maligniteit cervix,TC813,M13,SC7,DTC245809,43.0,255,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-06 09:00:00,0.0,6.0,0.0,9.0,8640000.0,0.0,1
34013,Gynaecologische tumoren,TC61,DC106,SC7,other,78.0,258,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-08 09:00:00,0.0,6.0,2.0,9.0,61689600.0,0.0,1
34229,maligniteit ovarium,TC102,DC821,SC13,DTC255196,51.0,259,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-08 09:00:00,0.0,6.0,2.0,9.0,40521600.0,0.0,1
34312,maligniteit ovarium | tuba,TC101,M16,SC7,DTC247894,42.0,261,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-08 09:00:00,0.0,6.0,2.0,9.0,56073600.0,0.0,1
34379,Gynaecologische tumoren,TC101,DC106,SC61,DTC390450,68.0,265,AC378607,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-06-13 09:00:00,0.0,6.0,0.0,9.0,87177600.0,0.0,1
34879,Gynaecologische tumoren,TC803,DC106,SC61,DTC390652,54.0,270,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-06-15 09:00:00,0.0,6.0,2.0,9.0,87091200.0,0.0,1
34928,maligniteit ovarium | tuba,TC101,M16,SC7,DTC252273,45.0,272,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-15 09:00:00,0.0,6.0,2.0,9.0,82166400.0,0.0,1
34931,maligniteit vagina,TC101,M12,SC7,DTC253376,65.0,273,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-16 09:00:00,0.0,6.0,3.0,9.0,604800.0,0.0,1
35018,maligniteit cervix,TC101,M13,SC7,DTC279467,39.0,276,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-18 09:00:00,0.0,6.0,5.0,9.0,81475200.0,0.0,1
35027,maligniteit vulva,TC101,M11,SC7,other,82.0,277,AC10307,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-19 09:00:00,0.0,6.0,6.0,9.0,75254400.0,0.0,1
35178,maligniteit cervix,TC101,M13,SC7,other,53.0,281,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-22 09:00:00,0.0,6.0,2.0,9.0,63676800.0,0.0,1
35182,maligniteit cervix,TC101,M13,SC7,other,36.0,282,AC10307,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-22 09:00:00,0.0,6.0,2.0,9.0,4665600.0,0.0,1
35479,maligniteit ovarium | tuba,TC101,M16,SC7,other,56.0,284,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-22 09:00:00,0.0,6.0,2.0,9.0,31276800.0,0.0,1
35655,maligniteit ovarium | tuba,TC803,M16,SC7,DTC281336,48.0,286,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-06-23 09:00:00,0.0,6.0,3.0,9.0,78624000.0,0.0,1
35665,maligniteit vulva,TC101,M11,SC7,other,67.0,287,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-24 09:00:00,0.0,6.0,4.0,9.0,69984000.0,0.0,1
35868,Gynaecologische tumoren,TC61,M14,SC61,DTC390438,67.0,290,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2005-06-29 09:00:00,0.0,6.0,2.0,9.0,59961600.0,0.0,1
35923,Adenoca: corpus uteri st Ic,TC101,M14,SC7,other,69.0,292,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-29 09:00:00,0.0,6.0,2.0,9.0,70761600.0,0.0,1
36077,Gynaecologische tumoren,TC61,DC106,SC7,DTC261957,33.0,295,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-06-30 09:00:00,0.0,6.0,3.0,9.0,73872000.0,0.0,1
37630,maligniteit cervix,TC101,M13,SC7,DTC266586,46.0,313,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-07 09:00:00,0.0,7.0,3.0,9.0,19353600.0,0.0,1
37658,maligniteit vulva,TC101,M11,SC7,other,91.0,316,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-11 09:00:00,0.0,7.0,0.0,9.0,70416000.0,0.0,1
38116,maligniteit ovarium | tuba,TC803,M16,SC7,DTC270800,70.0,321,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-13 09:00:00,0.0,7.0,2.0,9.0,1641600.0,0.0,1
38223,maligniteit vulva,TC503,M11,SC7,DTC387193,86.0,323,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-14 09:00:00,0.0,7.0,3.0,9.0,51753600.0,0.0,1
38344,maligniteit cervix,TC603,M13,SC7,DTC272449,45.0,326,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-15 09:00:00,0.0,7.0,4.0,9.0,70416000.0,0.0,1
38643,maligniteit cervix,TC803,M13,SC7,DTC273413,46.0,327,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-15 09:00:00,0.0,7.0,4.0,9.0,78278400.0,0.0,1
38831,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC293602,46.0,328,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-18 09:00:00,0.0,7.0,0.0,9.0,42336000.0,0.0,1
40341,maligniteit ovarium | tuba,TC101,M16,SC7,DTC275943,67.0,337,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-21 09:00:00,0.0,7.0,3.0,9.0,7171200.0,0.0,1
40761,Maligne neoplasma cervix uteri,TC813,DC822,SC61,DTC317614,67.0,339,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-25 09:00:00,0.0,7.0,0.0,9.0,73440000.0,0.0,1
41201,Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC307557,38.0,340,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-25 09:00:00,0.0,7.0,0.0,9.0,61862400.0,0.0,1
41667,maligniteit ovarium | tuba,TC803,M16,SC7,DTC279291,76.0,342,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-07-27 09:00:00,0.0,7.0,2.0,9.0,18576000.0,0.0,1
41713,maligniteit ovarium | tuba,TC101,M16,SC7,other,64.0,343,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-27 09:00:00,0.0,7.0,2.0,9.0,4838400.0,0.0,1
42050,maligniteit vulva,TC803,M11,SC7,DTC279921,86.0,344,AC359999,LVPT,Section 4,SC88,Pathology,1.0,2005-07-28 09:00:00,0.0,7.0,3.0,9.0,14601600.0,0.0,1
42641,maligniteit cervix,TC113,M13,SC7,DTC280007,35.0,347,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-28 09:00:00,0.0,7.0,3.0,9.0,1209600.0,0.0,1
42649,maligniteit cervix,TC101,M13,SC7,other,87.0,349,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-07-29 09:00:00,0.0,7.0,4.0,9.0,10108800.0,0.0,1
42924,Gynaecologische tumoren,TC13,M13,SC61,DTC390780,42.0,354,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-08-04 09:00:00,0.0,8.0,3.0,9.0,70070400.0,0.0,1
42966,maligniteit vulva,TC101,M11,SC7,DTC294837,63.0,355,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-05 09:00:00,0.0,8.0,4.0,9.0,53654400.0,0.0,1
43336,Gynaecologische tumoren,TC61,DC106,SC61,DTC808867,36.0,357,AC386902,SRA4,Section 5,SC62,Radiology,1.0,2005-08-05 09:00:00,0.0,8.0,4.0,9.0,63936000.0,0.0,1
44390,Gynaecologische tumoren,TC61,DC106,SC7,other,74.0,369,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-21 09:00:00,0.0,8.0,6.0,9.0,70416000.0,0.0,1
44411,maligniteit vulva,TC101,M11,SC7,DTC368280,50.0,370,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-22 09:00:00,0.0,8.0,0.0,9.0,75772800.0,0.0,1
44700,maligniteit cervix,TC101,M13,SC7,DTC294386,35.0,372,AC378720,STOL,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-08-23 09:00:00,0.0,8.0,1.0,9.0,1382400.0,0.0,1
45982,maligniteit cervix,TC813,M13,SC61,DTC355500,53.0,376,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-24 09:00:00,0.0,8.0,2.0,9.0,37929600.0,0.0,1
47192,Maligne neoplasma cervix uteri,TC3301,DC822,SC7,DTC298954,54.0,378,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-08-27 09:00:00,0.0,8.0,5.0,9.0,72921600.0,0.0,1
47534,Maligne neoplasma cervix uteri,TC61,DC822,SC61,DTC312531,53.0,379,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-08-29 09:00:00,0.0,8.0,0.0,9.0,74649600.0,0.0,1
47611,Gynaecologische tumoren,TC103,DC106,SC61,DTC390975,51.0,381,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-08-31 09:00:00,0.0,8.0,2.0,9.0,52704000.0,0.0,1
48393,maligniteit cervix,TC3101,DC822,SC13,DTC352318,44.0,386,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-05 09:00:00,0.0,9.0,0.0,9.0,29721600.0,0.0,1
49116,maligniteit cervix,TC101,M13,SC7,other,51.0,389,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-06 09:00:00,0.0,9.0,1.0,9.0,6652800.0,0.0,1
49165,Gynaecologische tumoren,TC61,DC106,SC7,other,49.0,393,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-07 09:00:00,0.0,9.0,2.0,9.0,78624000.0,0.0,1
49174,Gynaecologische tumoren,TC61,DC106,SC7,other,85.0,394,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-07 09:00:00,0.0,9.0,2.0,9.0,64108800.0,0.0,1
49641,maligniteit vulva,TC101,M11,SC7,other,73.0,398,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-08 09:00:00,0.0,9.0,3.0,9.0,54950400.0,0.0,1
49857,maligniteit vulva,TC803,M11,SC7,DTC306302,85.0,399,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-08 09:00:00,0.0,9.0,3.0,9.0,14515200.0,0.0,1
49931,maligniteit vulva,TC503,M11,SC7,DTC306088,59.0,400,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-08 09:00:00,0.0,9.0,3.0,9.0,64108800.0,0.0,1
49941,maligniteit cervix,TC101,M13,SC7,DTC306035,44.0,401,AC355427,LVPT,Section 4,SC88,Pathology,1.0,2005-09-08 09:00:00,0.0,9.0,3.0,9.0,64108800.0,0.0,1
49952,maligniteit cervix,TC101,M13,SC7,other,43.0,402,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-08 09:00:00,0.0,9.0,3.0,9.0,79056000.0,0.0,1
50436,maligniteit cervix,TC101,M13,SC7,other,70.0,405,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-10 09:00:00,0.0,9.0,5.0,9.0,34300800.0,0.0,1
50451,maligniteit ovarium | tuba,TC101,M16,SC7,DTC353566,71.0,406,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-10 09:00:00,0.0,9.0,5.0,9.0,63936000.0,0.0,1
50462,maligniteit vulva,TC101,M11,SC7,other,76.0,409,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-14 09:00:00,0.0,9.0,2.0,9.0,64713600.0,0.0,1
50594,maligniteit ovarium | tuba,TC803,M16,SC7,DTC310361,65.0,413,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-15 09:00:00,0.0,9.0,3.0,9.0,16070400.0,0.0,1
50671,maligniteit cervix,TC103,M13,SC7,DTC349400,43.0,414,370401S,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-16 09:00:00,0.0,9.0,4.0,9.0,5356800.0,0.0,1
50738,maligniteit ovarium | tuba,TC101,M16,SC7,DTC333849,60.0,415,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-16 09:00:00,0.0,9.0,4.0,9.0,60912000.0,0.0,1
50739,maligniteit vulva,TC101,M11,SC7,DTC312551,69.0,416,AC10107,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-19 09:00:00,0.0,9.0,0.0,9.0,0.0,0.0,1
50971,maligniteit vulva,TC101,M11,SC7,other,79.0,418,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-21 09:00:00,0.0,9.0,2.0,9.0,0.0,0.0,1
51479,maligniteit ovarium | tuba,TC703,M16,SC7,DTC314265,67.0,422,330001B,PLAB,Section 4,SC20,General Lab Clinical Chemistry,1.0,2005-09-21 09:00:00,0.0,9.0,2.0,9.0,7257600.0,0.0,1
51510,maligniteit vulva,TC101,M11,SC7,other,80.0,423,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-22 09:00:00,0.0,9.0,3.0,9.0,16848000.0,0.0,1
51518,maligniteit vulva,TC101,M11,SC7,other,81.0,424,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-22 09:00:00,0.0,9.0,3.0,9.0,67651200.0,0.0,1
51640,maligniteit ovarium | tuba,TC101,M16,SC7,other,84.0,430,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-09-26 09:00:00,0.0,9.0,0.0,9.0,70416000.0,0.0,1
51983,maligniteit vulva,TC803,M11,SC7,DTC320668,65.0,433,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-09-29 09:00:00,0.0,9.0,3.0,9.0,68256000.0,0.0,1
52060,maligniteit endometrium,TC101,M14,SC7,other,61.0,439,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-01 09:00:00,0.0,10.0,5.0,9.0,43891200.0,0.0,1
52663,maligniteit cervix,TC503,M13,SC7,DTC324178,35.0,444,378619A,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-10-05 09:00:00,0.0,10.0,2.0,9.0,9849600.0,0.0,1
52835,Maligne neoplasma cervix uteri,TC103,DC822,SC61,DTC341092,80.0,446,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-10-06 09:00:00,0.0,10.0,3.0,9.0,65404800.0,0.0,1
53259,maligniteit ovarium | tuba,TC101,M16,SC7,DTC373608,80.0,449,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-07 09:00:00,0.0,10.0,4.0,9.0,74131200.0,0.0,1
53686,maligniteit ovarium | tuba,TC3301,DC821,SC13,DTC337908,71.0,453,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-12 09:00:00,0.0,10.0,2.0,9.0,9072000.0,0.0,1
54191,maligniteit cervix,TC103,M13,SC61,DTC333256,35.0,457,AC419100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-10-18 09:00:00,0.0,10.0,1.0,9.0,8035200.0,0.0,1
54201,maligniteit vulva,TC101,M11,SC7,other,60.0,458,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-19 09:00:00,0.0,10.0,2.0,9.0,68256000.0,0.0,1
54203,maligniteit vulva,TC101,M11,SC7,other,86.0,459,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-19 09:00:00,0.0,10.0,2.0,9.0,0.0,0.0,1
54209,maligniteit cervix,TC101,M13,SC7,other,50.0,460,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-19 09:00:00,0.0,10.0,2.0,9.0,47174400.0,0.0,1
54456,maligniteit cervix,TC3101,DC822,SC13,DTC336986,38.0,464,AC419100,SIOG,Section 1,SC13,Internal Specialisms clinic,1.0,2005-10-24 09:00:00,0.0,10.0,0.0,9.0,7862400.0,0.0,1
54676,maligniteit cervix,TC502,M13,SC7,DTC338649,30.0,467,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-26 09:00:00,0.0,10.0,2.0,9.0,67737600.0,0.0,1
55399,Maligne neoplasma cervix uteri,TC61,M13,SC61,DTC347653,59.0,468,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-10-26 09:00:00,0.0,10.0,2.0,9.0,23068800.0,0.0,1
55539,maligniteit cervix,TC101,M13,SC7,DTC339449,29.0,471,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-27 09:00:00,0.0,10.0,3.0,9.0,74390400.0,0.0,1
55542,maligniteit cervix,TC101,M13,SC7,other,45.0,472,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-27 09:00:00,0.0,10.0,3.0,9.0,0.0,0.0,1
55717,maligniteit ovarium | tuba,TC101,M16,SC7,DTC377196,36.0,476,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-10-28 09:00:00,0.0,10.0,4.0,9.0,66268800.0,0.0,1
56040,Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684700,36.0,477,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-10-31 09:00:00,0.0,10.0,0.0,9.0,71625600.0,0.0,1
56075,maligniteit cervix,TC101,M13,SC7,DTC342888,30.0,478,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-02 09:00:00,0.0,11.0,2.0,9.0,48988800.0,0.0,1
56313,maligniteit endometrium,TC101,M14,SC7,DTC357172,54.0,482,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-05 09:00:00,0.0,11.0,5.0,9.0,17280000.0,0.0,1
56363,maligniteit ovarium | tuba,TC101,M16,SC7,other,42.0,484,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-07 09:00:00,0.0,11.0,0.0,9.0,0.0,0.0,1
56374,maligniteit vulva,TC101,M11,SC7,other,53.0,486,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-09 09:00:00,0.0,11.0,2.0,9.0,47779200.0,0.0,1
56916,Mucineus adenoca. ovarium st IIIc,TC803,M16,SC7,DTC348215,49.0,492,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-09 09:00:00,0.0,11.0,2.0,9.0,7257600.0,0.0,1
56970,maligniteit cervix,TC101,M13,SC7,DTC349433,32.0,494,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-10 09:00:00,0.0,11.0,3.0,9.0,24796800.0,0.0,1
57756,Maligne neoplasma ovarium,TC4401,DC821,SC13,DTC495326,44.0,495,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-11 09:00:00,0.0,11.0,4.0,9.0,62553600.0,0.0,1
58099,Gynaecologische tumoren,TC61,DC106,SC7,other,54.0,500,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-16 09:00:00,0.0,11.0,2.0,9.0,64108800.0,0.0,1
58598,Maligne neoplasma cervix uteri,TC103,DC822,SC61,DTC366424,44.0,507,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-11-28 09:00:00,0.0,11.0,0.0,9.0,61689600.0,0.0,1
58771,maligniteit cervix,TC101,M13,SC7,other,42.0,510,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-11-30 09:00:00,0.0,11.0,2.0,9.0,0.0,0.0,1
58909,maligniteit vulva,TC101,M11,SC7,other,65.0,513,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-12-01 09:00:00,0.0,12.0,3.0,9.0,29030400.0,0.0,1
58942,Gynaecologische tumoren,TC61,DC106,SC7,DTC364462,63.0,515,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-01 09:00:00,0.0,12.0,3.0,9.0,50198400.0,0.0,1
58970,maligniteit vulva,TC101,M11,SC7,other,51.0,516,AC10307,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-12-02 09:00:00,0.0,12.0,4.0,9.0,63849600.0,0.0,1
59865,Maligne neoplasma cervix uteri,TC613,DC822,SC61,DTC386069,53.0,517,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-05 09:00:00,0.0,12.0,0.0,9.0,60048000.0,0.0,1
62170,maligniteit ovarium | tuba,TC603,M16,SC7,DTC371732,65.0,522,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-12 09:00:00,0.0,12.0,0.0,9.0,2851200.0,0.0,1
62214,maligniteit vagina,TC102,M12,SC7,DTC374377,60.0,524,AC40016,H5ZU,Section 2,SC7,Nursing ward,1.0,2005-12-14 09:00:00,0.0,12.0,2.0,9.0,0.0,0.0,1
63659,maligniteit cervix,TC101,M13,SC7,other,59.0,527,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-12-19 09:00:00,0.0,12.0,0.0,9.0,68428800.0,0.0,1
63990,maligniteit vulva,TC3101,DC839,SC13,DTC408905,56.0,530,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2005-12-21 09:00:00,0.0,12.0,2.0,9.0,17020800.0,0.0,1
66817,Gynaecologische tumoren,TC11,DC106,SC61,DTC408061,61.0,536,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-29 09:00:00,0.0,12.0,3.0,9.0,62380800.0,0.0,1
67270,Maligne neoplasma ovarium,TC9101,DC821,SC7,DTC384420,66.0,537,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2005-12-29 09:00:00,0.0,12.0,3.0,9.0,68947200.0,0.0,1
68038,maligniteit cervix,other,M13,SC7,other,45.0,542,AC410100,SGIC,Section 2,SC7,Nursing ward,1.0,2006-01-03 09:00:00,0.0,1.0,1.0,9.0,12182400.0,0.0,1
70463,Gynaecologische tumoren,TC101,DC106,SC61,DTC575083,59.0,551,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-11 09:00:00,0.0,1.0,2.0,9.0,67219200.0,0.0,1
70640,maligniteit ovarium | tuba,TC3101,DC821,SC13,DTC582597,40.0,554,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-12 09:00:00,0.0,1.0,3.0,9.0,23932800.0,0.0,1
70656,maligniteit ovarium | tuba,TC101,M16,SC7,other,48.0,556,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-12 09:00:00,0.0,1.0,3.0,9.0,36288000.0,0.0,1
71915,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC416207,44.0,562,AC370423,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-18 09:00:00,0.0,1.0,2.0,9.0,64713600.0,0.0,1
71960,maligniteit cervix,TC61,DC106,SC61,DTC841377,50.0,563,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-18 09:00:00,0.0,1.0,2.0,9.0,33177600.0,0.0,1
72194,maligniteit cervix,TC101,M13,SC7,other,61.0,566,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-19 09:00:00,0.0,1.0,3.0,9.0,50803200.0,0.0,1
72216,maligniteit endometrium,TC101,M14,SC7,DTC399888,48.0,569,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-01-19 09:00:00,0.0,1.0,3.0,9.0,66528000.0,0.0,1
72738,Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC626861,36.0,571,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-25 09:00:00,0.0,1.0,2.0,9.0,47174400.0,0.0,1
73875,Maligne neoplasma ovarium,TC803,DC821,SC13,DTC468383,43.0,582,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-01-31 09:00:00,0.0,1.0,1.0,9.0,67132800.0,0.0,1
74178,Maligne neoplasma ovarium,TC803,DC821,SC61,DTC622045,56.0,585,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-01 09:00:00,0.0,2.0,2.0,9.0,66441600.0,0.0,1
74421,maligniteit vulva,TC101,M11,SC7,other,58.0,588,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-08 09:00:00,0.0,2.0,2.0,9.0,16329600.0,0.0,1
74427,maligniteit cervix,TC101,M13,SC7,other,44.0,589,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-08 09:00:00,0.0,2.0,2.0,9.0,64800000.0,0.0,1
75035,Maligne neoplasma cervix uteri,TC3301,DC822,SC61,DTC429774,38.0,591,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-08 09:00:00,0.0,2.0,2.0,9.0,66614400.0,0.0,1
75315,Plaveiselcelcarcinoom cervix (nno),TC103,M13,SC7,DTC413918,36.0,594,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-09 09:00:00,0.0,2.0,3.0,9.0,65750400.0,0.0,1
75636,Gynaecologische tumoren,TC62,DC106,SC61,DTC841442,46.0,595,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-02-09 09:00:00,0.0,2.0,3.0,9.0,65318400.0,0.0,1
76187,maligniteit vulva,TC101,M11,SC7,DTC418025,28.0,598,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-02-15 09:00:00,0.0,2.0,2.0,9.0,10713600.0,0.0,1
76229,Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC418173,61.0,599,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-15 09:00:00,0.0,2.0,2.0,9.0,64713600.0,0.0,1
76315,maligniteit vulva,TC101,M11,SC7,other,92.0,604,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-02-16 09:00:00,0.0,2.0,3.0,9.0,0.0,0.0,1
76563,Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC448179,29.0,606,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-02-16 09:00:00,0.0,2.0,3.0,9.0,55382400.0,0.0,1
76941,maligniteit vulva,TC101,M11,SC7,DTC426794,86.0,616,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-01 09:00:00,0.0,3.0,2.0,9.0,56764800.0,0.0,1
77204,maligniteit cervix,TC803,M13,SC7,DTC429785,41.0,619,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-06 09:00:00,0.0,3.0,0.0,9.0,29894400.0,0.0,1
77625,maligniteit ovarium | tuba,TC101,M16,SC7,other,40.0,621,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-03-06 09:00:00,0.0,3.0,0.0,9.0,0.0,0.0,1
78090,maligniteit cervix,TC101,M13,SC7,DTC430507,46.0,623,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-07 09:00:00,0.0,3.0,1.0,9.0,33868800.0,0.0,1
79329,Maligne neoplasma cervix uteri,TC9102,DC822,SC61,DTC438991,49.0,625,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-08 09:00:00,0.0,3.0,2.0,9.0,56678400.0,0.0,1
79955,Maligne neoplasma cervix uteri,TC3301,M13,SC61,DTC435615,31.0,629,370712B,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-09 09:00:00,0.0,3.0,3.0,9.0,16329600.0,0.0,1
79987,Gynaecologische tumoren,TC61,DC106,SC7,DTC432315,69.0,630,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-09 09:00:00,0.0,3.0,3.0,9.0,50803200.0,0.0,1
80532,Maligne neoplasma cervix uteri,TC113,DC822,SC61,DTC448136,71.0,632,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-13 09:00:00,0.0,3.0,0.0,9.0,58320000.0,0.0,1
80569,maligniteit endometrium,TC101,M14,SC7,other,65.0,633,AC355427,LVPT,Section 4,SC88,Pathology,1.0,2006-03-13 09:00:00,0.0,3.0,0.0,9.0,33955200.0,0.0,1
80595,maligniteit endometrium,TC101,M14,SC7,DTC434242,43.0,634,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-13 09:00:00,0.0,3.0,0.0,9.0,62553600.0,0.0,1
80945,maligniteit vulva,TC101,M11,SC7,other,59.0,638,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-15 09:00:00,0.0,3.0,2.0,9.0,52617600.0,0.0,1
80971,maligniteit cervix,TC61,DC106,SC61,other,34.0,640,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-15 09:00:00,0.0,3.0,2.0,9.0,16416000.0,0.0,1
81917,maligniteit myometrium,TC603,M15,SC7,DTC440344,74.0,644,AC370442,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-17 09:00:00,0.0,3.0,4.0,9.0,1641600.0,0.0,1
82034,maligniteit endometrium,TC101,M14,SC7,other,46.0,646,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-20 09:00:00,0.0,3.0,0.0,9.0,34646400.0,0.0,1
82197,Adenoca: corpus uteri st IIIa,TC803,M14,SC7,DTC440930,73.0,651,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-03-22 09:00:00,0.0,3.0,2.0,9.0,61862400.0,0.0,1
82680,Gynaecologische tumoren,TC101,DC106,SC61,DTC803570,69.0,658,AC386002,SRA1,Section 5,SC62,Radiology,1.0,2006-03-29 09:00:00,0.0,3.0,2.0,9.0,51235200.0,0.0,1
82841,maligniteit ovarium | tuba,TC101,M16,SC7,DTC446336,47.0,662,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-03-30 09:00:00,0.0,3.0,3.0,9.0,5356800.0,0.0,1
83427,Gynaecologische tumoren,TC13,DC106,SC61,DTC574951,38.0,667,370488E,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-05 09:00:00,0.0,4.0,2.0,9.0,52531200.0,0.0,1
84450,Plav.celcarc. vulva: st III1,TC613,M11,SC7,DTC455793,89.0,673,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-12 09:00:00,0.0,4.0,2.0,9.0,14515200.0,0.0,1
84454,maligniteit cervix,TC101,M13,SC7,other,50.0,674,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-12 09:00:00,0.0,4.0,2.0,9.0,30931200.0,0.0,1
84734,Maligne neoplasma cervix uteri,TC3101,DC822,SC7,DTC455470,44.0,675,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-12 09:00:00,0.0,4.0,2.0,9.0,8380800.0,0.0,1
85549,maligniteit endometrium,TC101,M14,SC7,other,59.0,679,AC411100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-13 09:00:00,0.0,4.0,3.0,9.0,52012800.0,0.0,1
85810,Sereus adenoca: ovarium st IIIc,TC603,M16,SC7,DTC458491,63.0,681,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-18 09:00:00,0.0,4.0,1.0,9.0,7344000.0,0.0,1
85952,maligniteit cervix,TC803,M13,SC7,DTC459519,36.0,683,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-04-19 09:00:00,0.0,4.0,2.0,9.0,8294400.0,0.0,1
86204,maligniteit endometrium,TC101,M14,SC7,other,62.0,686,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-04-19 09:00:00,0.0,4.0,2.0,9.0,1296000.0,0.0,1
86708,Gynaecologische tumoren,TC13,DC106,SC7,DTC469372,71.0,692,AC419100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-03 09:00:00,0.0,5.0,2.0,9.0,57110400.0,0.0,1
87115,Maligne nieuwv. cervix uteri (ov),TC61,DC106,SC61,DTC803593,58.0,697,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-08 09:00:00,0.0,5.0,0.0,9.0,57456000.0,0.0,1
87136,"Plaveiselcelca, cervix st Ib",TC101,M13,SC7,DTC472041,39.0,698,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-08 09:00:00,0.0,5.0,0.0,9.0,8467200.0,0.0,1
87168,maligniteit myometrium,TC101,M15,SC7,other,43.0,699,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-08 09:00:00,0.0,5.0,0.0,9.0,3196800.0,0.0,1
87252,maligniteit endometrium,TC101,M14,SC7,DTC473664,51.0,702,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-10 09:00:00,0.0,5.0,2.0,9.0,6134400.0,0.0,1
87261,Sereus adenoca: ovarium st IIIc,TC104,M16,SC7,DTC473952,63.0,703,AC355111,LVPT,Section 4,SC88,Pathology,1.0,2006-05-10 09:00:00,0.0,5.0,2.0,9.0,0.0,0.0,1
87445,"Plaveiselcelca, cervix st IIIb",TC113,M13,SC7,DTC474860,80.0,704,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-11 09:00:00,0.0,5.0,3.0,9.0,2332800.0,0.0,1
87478,maligniteit cervix,TC101,M13,SC7,other,57.0,706,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-15 09:00:00,0.0,5.0,0.0,9.0,0.0,0.0,1
87508,maligniteit endometrium,TC13,DC106,SC61,DTC575182,72.0,707,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-15 09:00:00,0.0,5.0,0.0,9.0,2505600.0,0.0,1
87702,maligniteit ovarium | tuba,TC101,M16,SC7,DTC477548,27.0,709,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-16 09:00:00,0.0,5.0,1.0,9.0,52012800.0,0.0,1
88209,Adenoca: corpus uteri st IVb,TC3103,DC823,SC13,DTC496853,76.0,713,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-18 09:00:00,0.0,5.0,3.0,9.0,2419200.0,0.0,1
88273,other,TC101,M16,SC7,other,39.0,715,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-18 09:00:00,0.0,5.0,3.0,9.0,21772800.0,0.0,1
88547,maligniteit vulva,TC101,M11,SC7,other,80.0,719,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-05-24 09:00:00,0.0,5.0,2.0,9.0,0.0,0.0,1
88738,Metastasen maligniteit ovarium (nno),TC101,M16,SC7,DTC484397,75.0,721,376400.0,CHE1,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-05-24 09:00:00,0.0,5.0,2.0,9.0,518400.0,0.0,1
89938,Sereus adenoca: ovarium st IV,TC803,M16,SC7,DTC489159,44.0,725,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-01 09:00:00,0.0,6.0,3.0,9.0,28339200.0,0.0,1
90312,"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC493191,41.0,730,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-08 09:00:00,0.0,6.0,3.0,9.0,48384000.0,0.0,1
90394,Recidieven (borderline) mal. ovarium (nno),TC104,M16,SC7,DTC493308,56.0,733,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-08 09:00:00,0.0,6.0,3.0,9.0,0.0,0.0,1
91027,Plaveiselcelcarcinoom cervix (nno),TC104,M13,SC7,other,37.0,737,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-12 09:00:00,0.0,6.0,0.0,9.0,0.0,0.0,1
91964,Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC538878,57.0,741,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-14 09:00:00,0.0,6.0,2.0,9.0,40953600.0,0.0,1
92774,Maligne neoplasma cervix uteri,TC62,M13,SC61,DTC511602,34.0,742,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-16 09:00:00,0.0,6.0,4.0,9.0,29721600.0,0.0,1
93372,Maligne neoplasma ovarium,TC603,DC821,SC13,DTC540087,42.0,745,370407.0,HAEM,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-19 09:00:00,0.0,6.0,0.0,9.0,55036800.0,0.0,1
94013,Maligne neoplasma ovarium,TC803,DC821,SC13,DTC538834,61.0,746,other,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-19 09:00:00,0.0,6.0,0.0,9.0,52617600.0,0.0,1
94057,maligniteit ovarium | tuba,TC101,M16,SC7,other,72.0,747,AC415100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-21 09:00:00,0.0,6.0,2.0,9.0,691200.0,0.0,1
94188,Recidieven (borderline) mal. ovarium (nno),TC103,M16,SC13,DTC506782,76.0,748,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-06-22 09:00:00,0.0,6.0,3.0,9.0,26697600.0,0.0,1
94472,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC508688,59.0,756,AC370402,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-06-28 09:00:00,0.0,6.0,2.0,9.0,10800000.0,0.0,1
94593,Plav.celcarc. vulva: st IVb,TC101,M11,SC7,DTC511489,51.0,759,AC379999,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-03 09:00:00,0.0,7.0,0.0,9.0,27993600.0,0.0,1
95065,Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC513558,55.0,763,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-05 09:00:00,0.0,7.0,2.0,9.0,51494400.0,0.0,1
95192,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC513391,66.0,764,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-05 09:00:00,0.0,7.0,2.0,9.0,7084800.0,0.0,1
95368,"Plaveiselcelca, cervix st Ib",TC803,M13,SC7,DTC515302,48.0,766,AC370604,BLOB,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-07 09:00:00,0.0,7.0,4.0,9.0,52531200.0,0.0,1
95454,maligniteit cervix,TC101,M13,SC7,other,41.0,769,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-12 09:00:00,0.0,7.0,2.0,9.0,30844800.0,0.0,1
95730,Plav.celcarc. vulva: st I,TC803,M11,SC7,DTC520142,84.0,772,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-14 09:00:00,0.0,7.0,4.0,9.0,52444800.0,0.0,1
95791,Recidieven maligniteit ovarium,TC803,M16,SC7,DTC521134,58.0,773,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-07-17 09:00:00,0.0,7.0,0.0,9.0,51062400.0,0.0,1
95819,maligniteit vulva,TC101,M11,SC7,other,80.0,774,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-19 09:00:00,0.0,7.0,2.0,9.0,0.0,0.0,1
96532,Maligne nieuwv. cervix uteri (nno),TC101,M13,SC7,other,40.0,786,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-07-27 09:00:00,0.0,7.0,3.0,9.0,604800.0,0.0,1
96891,other,TC101,M15,SC7,other,78.0,790,AC350503,LVPT,Section 4,SC88,Pathology,1.0,2006-08-02 09:00:00,0.0,8.0,2.0,9.0,86400.0,0.0,1
97096,Recidieven corpus maligniteit uteri (nno),TC13,DC106,SC61,DTC785413,66.0,792,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-04 09:00:00,0.0,8.0,4.0,9.0,12268800.0,0.0,1
97182,Plav.celcarc. vulva: st II,TC803,M11,SC7,DTC535072,76.0,793,AC355201,LVPT,Section 4,SC88,Pathology,1.0,2006-08-07 09:00:00,0.0,8.0,0.0,9.0,48470400.0,0.0,1
97304,Gynaecologische tumoren,TC13,M13,SC61,DTC785752,41.0,795,AC410100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-08-10 09:00:00,0.0,8.0,3.0,9.0,32572800.0,0.0,1
98390,Recidieven corpus maligniteit uteri (nno),TC101,M14,SC7,other,61.0,798,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-17 09:00:00,0.0,8.0,3.0,9.0,604800.0,0.0,1
100451,Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC545780,61.0,804,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-24 09:00:00,0.0,8.0,3.0,9.0,38620800.0,0.0,1
100485,maligniteit cervix,TC101,M13,SC7,other,40.0,806,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-08-28 09:00:00,0.0,8.0,0.0,9.0,0.0,0.0,1
101053,Ovariacarcinoom,TC3101,DC821,SC7,DTC549410,61.0,809,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-30 09:00:00,0.0,8.0,2.0,9.0,48902400.0,0.0,1
101563,Sereus adenoca: ovarium st IIIc,TC9101,DC821,SC13,DTC551869,70.0,810,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-08-30 09:00:00,0.0,8.0,2.0,9.0,24105600.0,0.0,1
103209,maligniteit cervix,TC113,M13,SC7,DTC556289,50.0,817,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-11 09:00:00,0.0,9.0,0.0,9.0,950400.0,0.0,1
106022,Maligne neoplasma cervix uteri,TC3101,DC822,SC61,DTC578502,71.0,826,AC356134,LVPT,Section 4,SC88,Pathology,1.0,2006-09-20 09:00:00,0.0,9.0,2.0,9.0,45532800.0,0.0,1
106791,Maligne neoplasma ovarium,TC3101,DC821,SC7,DTC569709,23.0,830,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-09-28 09:00:00,0.0,9.0,3.0,9.0,45100800.0,0.0,1
108001,Adenoca: corpus uteri st IIIa,TC103,M14,SC13,DTC617094,70.0,840,AC419100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-10-27 09:00:00,0.0,10.0,4.0,9.0,43804800.0,0.0,1
108730,Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC622032,54.0,846,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 09:00:00,0.0,11.0,0.0,9.0,37756800.0,0.0,1
108795,Adenoca:  cervix st Ib,TC503,M13,SC7,DTC596527,35.0,847,AC370443,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-06 09:00:00,0.0,11.0,0.0,9.0,7257600.0,0.0,1
109637,Gynaecologische tumoren,TC61,DC106,SC7,other,76.0,849,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-08 09:00:00,0.0,11.0,2.0,9.0,12528000.0,0.0,1
109718,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC598762,44.0,850,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-08 09:00:00,0.0,11.0,2.0,9.0,7948800.0,0.0,1
109969,Niet epitheliale mal. nieuwv. ovarium st Ia,TC101,M16,SC7,DTC601360,36.0,852,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-13 09:00:00,0.0,11.0,0.0,9.0,36979200.0,0.0,1
110045,Gynaecologische tumoren,TC101,DC106,SC61,DTC786076,85.0,853,370488J,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-15 09:00:00,0.0,11.0,2.0,9.0,33782400.0,0.0,1
111553,Adenoca: corpus uteri st IIIa,TC101,M14,SC7,other,76.0,859,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-29 09:00:00,0.0,11.0,2.0,9.0,0.0,0.0,1
111555,Sereus adenoca: ovarium st IIIc,TC101,M16,SC7,DTC613189,72.0,860,339486E,SGEC,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-29 09:00:00,0.0,11.0,2.0,9.0,0.0,0.0,1
111595,maligniteit cervix,TC101,M13,SC7,DTC613784,59.0,861,AC411100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-11-30 09:00:00,0.0,11.0,3.0,9.0,38102400.0,0.0,1
111805,Maligne neoplasma cervix uteri,TC3101,M13,SC61,DTC654390,34.0,862,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-11-30 09:00:00,0.0,11.0,3.0,9.0,35078400.0,0.0,1
112042,Endometrioid adenoca. ovarium st IIIc,TC101,M16,SC7,DTC618024,55.0,866,370401C,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-06 09:00:00,0.0,12.0,2.0,9.0,5875200.0,0.0,1
112072,Maligne nieuwv. cervix uteri (nno),TC101,M13,SC7,other,51.0,867,AC355427,LVPT,Section 4,SC88,Pathology,1.0,2006-12-07 09:00:00,0.0,12.0,3.0,9.0,1209600.0,0.0,1
112299,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC619680,69.0,870,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-08 09:00:00,0.0,12.0,4.0,9.0,18576000.0,0.0,1
112750,Adenoca: corpus uteri st Ic,TC23,DC106,SC61,DTC786031,83.0,873,AC370401,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2006-12-13 09:00:00,0.0,12.0,2.0,9.0,2505600.0,0.0,1
113254,maligniteit ovarium | tuba,TC101,M16,SC7,other,82.0,878,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2006-12-20 09:00:00,0.0,12.0,2.0,9.0,0.0,0.0,1
113291,Recidieven maligniteit cervix uteri,TC61,DC106,SC61,DTC803745,59.0,879,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2006-12-21 09:00:00,0.0,12.0,3.0,9.0,36892800.0,0.0,1
114701,Niet epitheliale mal. nieuwv. ovarium st onb.,TC3101,DC821,SC13,DTC712665,39.0,886,AC610001,H5ZU,Section 2,SC7,Nursing ward,-1.0,2007-01-15 09:00:00,0.0,1.0,0.0,9.0,31017600.0,0.0,1
115036,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC647284,48.0,889,AC355401,LVPT,Section 4,SC88,Pathology,1.0,2007-01-18 09:00:00,0.0,1.0,3.0,9.0,7948800.0,0.0,1
115132,"Plaveiselcelca, cervix st Ia1",TC603,M13,SC7,DTC647463,41.0,890,AC410100,SGAL,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-01-19 09:00:00,0.0,1.0,4.0,9.0,34732800.0,0.0,1
115444,Plaveiselcelcarcinoom cervix (nno),TC813,M13,SC61,DTC663298,53.0,891,AC370403,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-22 09:00:00,0.0,1.0,0.0,9.0,23328000.0,0.0,1
116436,Plaveiselcelcarcinoom cervix (nno),TC113,M13,SC61,DTC664302,30.0,894,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-01-30 09:00:00,0.0,1.0,1.0,9.0,24883200.0,0.0,1
117114,Maligne neoplasma cervix uteri,TC803,DC822,SC61,DTC684733,47.0,897,AC370000,CRLA,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-05 09:00:00,0.0,2.0,0.0,9.0,31622400.0,0.0,1
117147,Recidieven corpus maligniteit uteri (nno),TC101,M14,SC7,other,51.0,898,AC410100,SGNA,Section 2,SC7,Obstetrics & Gynaecology clinic,1.0,2007-02-07 09:00:00,0.0,2.0,2.0,9.0,86400.0,0.0,1
117603,Gynaecologische tumoren,TC13,DC106,SC7,DTC665031,68.0,901,AC419100,SRTH,Section 5,SC61,Radiotherapy,1.0,2007-02-14 09:00:00,0.0,2.0,2.0,9.0,4838400.0,0.0,1
117763,Adenoca: corpus uteri st IVb,TC103,M14,SC61,DTC698131,70.0,904,370488G,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 09:00:00,0.0,2.0,3.0,9.0,10800000.0,0.0,1
117905,Sereus adenoca: ovarium st IIIc,TC803,M16,SC7,DTC665661,51.0,906,AC370419,CHE2,Section 4,SC86,General Lab Clinical Chemistry,1.0,2007-02-15 09:00:00,0.0,2.0,3.0,9.0,6652800.0,0.0,1
